CRISPR-Edited Cells for Cancer Therapy Safe in Humans: Trial

In the first clinical study of its kind in the US, researchers used CRISPR to modify CAR T cells to make them more potent against cancer, but the clinical benefits are unknown.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news